PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Anticancer drug can spur immune system to fight infection

Low doses of Imatinib/Gleevec stimulate immune cell production

2015-04-01
(Press-News.org) Low doses of the anti-cancer drug imatinib can spur the bone marrow to produce more innate immune cells to fight against bacterial infections, Emory researchers have found.

The results were published March 30, 2015 in the journal PLOS Pathogens.

The findings suggest imatinib, known commercially as Gleevec , or related drugs could help doctors treat a wide variety of infections, including those that are resistant to antibiotics, or in patients who have weakened immune systems. The research was performed in mice and on human bone marrow cells in vitro, but provides information on how to dose imatinib for new clinical applications.

"We think that low doses of imatinib are mimicking 'emergency hematopoiesis,' a normal early response to infection," says senior author Daniel Kalman, PhD, professor of pathology and laboratory medicine at Emory University School of Medicine.

Imatinib, is an example of a "targeted therapy" against certain types of cancer. It,blocks tyrosine kinase enzymes, which are dysregulated in cancers such as chronic myelogenous leukemia and gastrointestinal stromal tumors.

Imatinib also inhibits normal forms of these enzymes that are found in healthy cells. Several pathogens - both bacteria and viruses - exploit these enzymes as they transit into, through, or out of human cells. Researchers have previously found that imatinib or related drugs can inhibit infection of cells by pathogens that are very different from each other, including tuberculosis bacteria and Ebola virus.

In the new PLOS Pathogens paper, Emory investigators show that imatinib can push the immune system to combat a variety of bacteria, even those that do not exploit Abl enzymes. The drug does so by stimulating the bone marrow to make more neutrophils and macrophages, immune cells that are important for resisting bacterial infection.

"This was surprising because there are reports that imatinib can be immunosuppressive in some patients," Kalman says. "Our data suggest that at sub-clinical doses, imatinib can stimulate bone marrow stem cells to produce several types of myeloid cells, such as neutrophils and macrophages, and trigger their exodus from the bone marrow. However, higher doses appear to inhibit this process."

The authors note that imatinib appears to stimulate several types of white blood cells, which may provide a limit on inflammation, rather than increasing neutrophils only, which can be harmful. The authors go on to suggest that imatinib or related drugs may be useful in treating a variety of infections in patients whose immune system is compromised, such as those receiving chemotherapy for cancer.

INFORMATION:

Co-first authors of the paper are former graduate students Ruth Napier (Microbiology and Molecular Genetics program) and Brian Norris (Immunology and Molecular Pathogenesis program). Collaborators from Emory's Departments of Hematology and Medical Oncology, Medicine, and Pediatrics, as well as from MD Anderson Cancer Center and Saint Louis University contributed to the paper.



ELSE PRESS RELEASES FROM THIS DATE:

Old cancer drug could have new use in fighting cancer

2015-04-01
COLUMBIA, Mo. - A drug used for decades to treat leukemia may have other uses in the fight against cancer, researchers at the University of Missouri have found. Previously, doctors used 6-Thioguanine, or 6-TG, as a chemotherapy treatment to kill cancer cells in patients with leukemia. In recent years, many doctors have shelved 6-TG in exchange for newer drugs that are more effective. Now, Jeffrey Bryan, an associate professor of oncology at the MU College of Veterinary Medicine, and his colleagues found that 6-TG can not only kill cancer cells, but also works to change ...

Texting too tempting for college students even when inappropriate

2015-04-01
College students may realize that texting in the shower or at a funeral is inappropriate, but many do it anyway, according to Penn State psychologists. "We have looked at inappropriate texting behavior -- texting while driving, for instance -- before, but what we wanted to find out is whether the people who are engaging in these forms of behavior even know whether or not it is the right thing to do," said Marissa Harrison, associate professor of psychology, Penn State Harrisburg. The researchers suggest that college students are not necessarily trying to create new ...

New in the Hastings Center Report April 2015

2015-04-01
Why It's Not Time for Health Care Rationing Peter A. Ubel There is a notable change in professional debates about how to better control health care costs. Discussion of health care rationing has become much more muted. "I contend that debates about health care rationing have waned not because the need to ration has dwindled nor because ethical debates about how or whether to ration have been resolved," writes Peter A. Ubel. They have declined because the word "rationing" has been replaced by terms such as "value" that "are not burdened by emotional and historical baggage." ...

Wayne State study of brain networks shows differences in children with OCD

2015-04-01
DETROIT - A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder. The research led by the Department of Psychiatry and Behavioral Neuroscience's David Rosenberg, M.D., and Vaibhav Diwadkar, Ph.D., sheds significant light on our understanding of how brain networks contribute to obsessive-compulsive disorder in youth. The study included youth with a diagnosis of OCD and a comparison group free of psychiatric illness. ...

Student helps to discover new pain relief delivery method

2015-04-01
A Chemistry undergraduate at the University of York has helped to develop a new drug release gel, which may help avoid some of the side effects of painkillers such as ibuprofen and naproxen. In a final year project, MChem undergraduate student Edward Howe, working in Professor David Smith's research team in the Department of Chemistry at York looked for a way of eliminating the adverse side-effects associated pain-killing drugs, particularly in the stomach, and the problems, such as ulceration, this could cause patients. Supervised by PhD student Babatunde Okesola, whose ...

Oral pain specialists treat complex health issues, according to new survey

2015-04-01
Andres Pinto, an orofacial pain and oral medicine specialist at Case Western Reserve University School of Dental Medicine, often feels like the doctor in the television series House, who solves medical mysteries each week. Pinto is among about 700 facial pain and oral medicine specialists nationally who patients often turn to when their own doctors are unable to identify and treat complex and rare medical conditions. In fact, according to a new study Pinto conducted with input from fellow members of the American Academy of Oral Medicine (AAOM), patients see, on average, ...

Migrating immune cells promote nerve cell demise in the brain

2015-04-01
A small area in the midbrain known as the substantia nigra is the control center for all bodily movement. Increasing loss of dopamine-generating neurons in this part of the brain therefore leads to the main symptoms of Parkinson's disease - slowness of movement, rigidity and shaking. In recent years, there has been increasing scientific evidence suggesting that inflammatory changes in the brain play a major role in Parkinson's. So far, it has been largely unclear whether this inflammation arises inside the brain itself or whether cells of the innate immune system that ...

Predicting chronic pain in whiplash injuries

2015-04-01
Large amount of fat in neck muscles predicts chronic pain, disability and PTSD Will enable earlier treatment for whiplash victims Fat indicates atrophy, shows the chronic pain is not psychological Whiplash affects more than 4 million Americans annually CHICAGO --- While most people should expect to fully recover from whiplash injuries within the first few months, about 25 percent have long-term pain and disability that lasts many months or years. Using special MRI imaging, Northwestern Medicine scientists have identified, within the first one and two weeks ...

Lifting families out of poverty -- with dignity

Lifting families out of poverty -- with dignity
2015-04-01
EAST LANSING, Mich. --- America's welfare state is quietly evolving from needs-based to an employment-based safety net that rewards working families and fuels dreams of a better life, indicates a new study led by a Michigan State University scholar. The major reason: the little-known Earned Income Tax Credit, a $65 billion federal tax-relief program for poor, working families. The program has been expanded dramatically during the past 25 years, while cash welfare has been sharply curtailed. Reporting in the April issue of the American Sociological Review, Jennifer Sykes ...

Story tips from the Department of Energy's Oak Ridge National Laboratory, April 2015

2015-04-01
ENVIRONMENT - Invertebrates' role in bioaccumulation ... By studying fish and invertebrates in a creek with known mercury contamination, researchers are gaining a better understanding of the relationship between the toxin in the stream and bioaccumulation in organisms. While mercury concentrations in East Fork Poplar Creek in Oak Ridge, Tenn., have decreased significantly over the last 30 years, levels in tissue from fish have remained the same or increased. To understand why, a team led by Monica Poteat of Oak Ridge National Laboratory is examining the intricacies of ...

LAST 30 PRESS RELEASES:

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

CCNY physicists uncover electronic interactions mediated via spin waves

Researchers’ 3D-printing formula may transform future of foam

Nurture more important than nature for robotic hand

Drug-delivering aptamers target leukemia stem cells for one-two knockout punch

New study finds that over 95% of sponsored influencer posts on Twitter were not disclosed

New sea grant report helps great lakes fish farmers navigate aquaculture regulations

Strain “trick” improves perovskite solar cells’ efficiency

How GPS helps older drivers stay on the roads

Estrogen and progesterone stimulate the body to make opioids

Dancing with the cells – how acoustically levitating a diamond led to a breakthrough in biotech automation

Machine learning helps construct an evolutionary timeline of bacteria

Cellular regulator of mRNA vaccine revealed... offering new therapeutic options

Animal behavioral diversity at risk in the face of declining biodiversity

Finding their way: GPS ignites independence in older adult drivers

Antibiotic resistance among key bacterial species plateaus over time

‘Some insects are declining but what’s happening to the other 99%?’

Powerful new software platform could reshape biomedical research by making data analysis more accessible

Revealing capillaries and cells in living organs with ultrasound

American College of Physicians awards $260,000 in grants to address equity challenges in obesity care

Researchers from MARE ULisboa discover that the European catfish, an invasive species in Portugal, has a prolonged breeding season, enhancing its invasive potential

Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research

Solar cells made of moon dust could power future space exploration

Deporting immigrants may further shrink the health care workforce

Border region emergency medical services in migrant emergency care

Resident physician intentions regarding unionization

Healthy nutrition and physical lifestyle choices lower cancer mortality risk for survivors, new ACS study finds

Mass General Brigham researchers reveal 17 modifiable risk factors shared by stroke, dementia, and late-life depression

Promising drug discovery research gets funding boost from Ontario Institute for Cancer Research

Carbon capture could become practical with scalable, affordable materials

[Press-News.org] Anticancer drug can spur immune system to fight infection
Low doses of Imatinib/Gleevec stimulate immune cell production